Paola Sestili
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, Cytokine Signaling Pathways and Interactions, Immune Cell Function and Interaction, CAR-T cell therapy research
Most-Cited Works
- → Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy(2014)1,012 cited
- → ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8α+ Dendritic Cells(2002)417 cited
- → Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis(2010)350 cited
- → Cyclophosphamide Enhances the Antitumor Efficacy of Adoptively Transferred Immune Cells through the Induction of Cytokine Expression, B-Cell and T-Cell Homeostatic Proliferation, and Specific Tumor Infiltration(2007)252 cited
- → Type I IFN as a Natural Adjuvant for a Protective Immune Response: Lessons from the Influenza Vaccine Model(2002)221 cited
- → ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells(2003)104 cited
- → Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level(2005)97 cited
- → IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing(2019)82 cited
- → Unraveling Cancer Chemoimmunotherapy Mechanisms by Gene and Protein Expression Profiling of Responses to Cyclophosphamide(2011)78 cited
- → Combining Type I Interferons and 5-Aza-2′-Deoxycitidine to Improve Anti-Tumor Response against Melanoma(2016)76 cited